ReWalk Robotics Ltd. (NASDAQ:LFWD – Get Free Report) Director Michael Swinford acquired 21,622 shares of the stock in a transaction dated Monday, November 25th. The shares were purchased at an average price of $2.03 per share, for a total transaction of $43,892.66. Following the completion of the transaction, the director now owns 65,040 shares of the company’s stock, valued at $132,031.20. This trade represents a 49.80 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Michael Swinford also recently made the following trade(s):
- On Friday, November 22nd, Michael Swinford purchased 16,907 shares of ReWalk Robotics stock. The shares were acquired at an average price of $1.83 per share, for a total transaction of $30,939.81.
- On Wednesday, November 20th, Michael Swinford acquired 16,471 shares of ReWalk Robotics stock. The stock was acquired at an average price of $1.84 per share, with a total value of $30,306.64.
ReWalk Robotics Trading Up 1.9 %
LFWD stock opened at $2.10 on Thursday. ReWalk Robotics Ltd. has a 1-year low of $1.70 and a 1-year high of $9.10. The business’s 50 day moving average is $2.54 and its 200-day moving average is $3.49. The firm has a market cap of $18.50 million, a P/E ratio of -0.84 and a beta of 2.07.
Analyst Ratings Changes
Separately, HC Wainwright reiterated a “buy” rating and set a $13.00 target price on shares of ReWalk Robotics in a research report on Wednesday, November 13th.
View Our Latest Analysis on LFWD
Institutional Investors Weigh In On ReWalk Robotics
A hedge fund recently bought a new stake in ReWalk Robotics stock. Dimensional Fund Advisors LP acquired a new position in shares of ReWalk Robotics Ltd. (NASDAQ:LFWD – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned about 0.16% of ReWalk Robotics at the end of the most recent quarter. 26.76% of the stock is currently owned by hedge funds and other institutional investors.
About ReWalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
Recommended Stories
- Five stocks we like better than ReWalk Robotics
- How to Invest in the FAANG Stocks
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What Are Growth Stocks and Investing in Them
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is the Hang Seng index?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.